Royalty Pharma acquires royalty stake in Alnylam's Amvuttra from Blackstone for $310m

Based in Cambridge, Massachusetts, Alynylam Pharmaceuticals is a biopharmaceutical firm.

4 November 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.